Nursing care
Metoclopramide: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Metoclopramide is a prokinetic and antiemetic that increases gastric motility, so it is contraindicated in bowel obstruction because it makes the gut contract against a physical block. Watch for extrapyramidal symptoms with any use and for tardive dyskinesia with prolonged use, since these are the effects most likely to be tested and most important to catch early.
Why this drug and not another
Metoclopramide works by blocking dopamine receptors and sensitising tissue to acetylcholine, which speeds gastric emptying and increases lower oesophageal sphincter tone. This makes it useful for diabetic gastroparesis, gastroesophageal reflux, and prevention of chemotherapy-induced or postoperative nausea and vomiting, situations where a prokinetic effect adds value beyond simple antiemetic action.
It is chosen over a non-prokinetic antiemetic such as ondansetron when delayed gastric emptying is part of the clinical picture, as in gastroparesis. It is not the right choice, and is in fact contraindicated, when the underlying problem is a mechanical block rather than sluggish motility, because increasing gut contraction against an obstruction can worsen pain, perforation risk, or bowel ischaemia.
Administration and timing
Oral doses are typically given thirty minutes before meals and at bedtime to take advantage of the prokinetic effect around eating, since the goal is to move food through a sluggish stomach before the next meal arrives. Intravenous doses should be given slowly, generally over at least one to two minutes, as rapid IV push increases the risk of restlessness and anxiety immediately after administration.
Dose reduction is required in renal impairment, since the drug is renally cleared and accumulation raises the risk of extrapyramidal effects. Duration of use should be kept as short as clinically necessary, generally not exceeding twelve weeks, because the risk of tardive dyskinesia rises with cumulative exposure.
Monitoring parameters
Monitor for early extrapyramidal symptoms after every dose change or new start: acute dystonia presenting as facial grimacing, torticollis, or oculogyric crisis, and akathisia presenting as an inability to sit still. These can appear within hours of a dose, particularly in younger patients and after intravenous administration.
For patients on longer courses, screen periodically for early tardive dyskinesia, which shows up as involuntary, repetitive movements of the face, tongue, or limbs such as lip smacking or tongue protrusion. Also monitor blood pressure, since metoclopramide can cause hypertension, and mental status, since it can worsen depression or cause new anxiety, particularly relevant in a patient with a prior mood disorder.
Adverse effects to report
Any new involuntary movement, muscle rigidity, or abnormal posturing should be reported immediately and treated as a possible extrapyramidal reaction, since acute dystonic reactions can be frightening and, if laryngeal, dangerous to the airway. Diphenhydramine or benztropine is commonly used to reverse an acute dystonic reaction and should be available.
Signs of neuroleptic malignant syndrome, though rare with metoclopramide, including high fever, severe muscle rigidity, altered mental status, and autonomic instability, require emergency treatment and immediate discontinuation. Persistent, repetitive facial or limb movements suggesting tardive dyskinesia should prompt stopping the drug and reporting to the prescriber, since this effect can become irreversible with continued use.
Contraindications and cautions
Metoclopramide is contraindicated in bowel obstruction, perforation, or gastrointestinal haemorrhage, because stimulating gut motility against a mechanical block can worsen the obstruction or increase perforation risk. It is also contraindicated in pheochromocytoma, since it can precipitate a hypertensive crisis, and in patients with a seizure disorder or Parkinson's disease, since it can lower seizure threshold and worsen parkinsonian symptoms through dopamine blockade.
Use with caution in patients with a history of depression, since metoclopramide carries a boxed warning for tardive dyskinesia and can also affect mood. Caution is also needed in older adults, who are more susceptible to extrapyramidal effects, and in patients on other dopamine-blocking agents, where the risk compounds.
Teaching points the exam tests
Teach the patient to take oral doses before meals and at bedtime as directed, and to report any unusual muscle movements, stiffness, or restlessness right away rather than waiting for the next appointment. This early reporting is what allows a dystonic reaction to be treated before it progresses.
Teach the patient that this medication is intended for short-term use and that long-term or repeated courses carry a real risk of tardive dyskinesia, a movement disorder that can persist even after the drug is stopped. A patient with known bowel obstruction, or with new severe abdominal pain and no bowel movements, should not receive this drug, and any nurse encountering that combination on an exam question should recognise it as the contraindication being tested.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our gastrointestinal practice questions are the closest set to what this page covers.
Common questions
Why is metoclopramide contraindicated in bowel obstruction?
Metoclopramide increases gastrointestinal motility by promoting stomach and bowel contraction. In a bowel obstruction, this stimulated contraction pushes against a physical block, which can worsen pain, increase pressure proximal to the obstruction, and raise the risk of perforation.
What is the difference between extrapyramidal symptoms and tardive dyskinesia with metoclopramide?
Extrapyramidal symptoms can appear early, even after a single dose, and include acute dystonia, akathisia, and drug-induced parkinsonism. Tardive dyskinesia develops with longer-term use and causes involuntary, repetitive movements, particularly of the face and tongue, that can become irreversible.
How long can a patient safely take metoclopramide?
Treatment is generally limited to twelve weeks or less because the risk of tardive dyskinesia rises with cumulative exposure. Any longer-term need should prompt reassessment of the underlying condition and consideration of alternative therapy.
What should be given for an acute dystonic reaction to metoclopramide?
Diphenhydramine or benztropine is typically administered to reverse an acute dystonic reaction. The drug should also be stopped and the prescriber notified, and the airway should be monitored closely if the reaction involves the larynx or throat.